|
1
|
- 1. What comments or suggestions does the committee
have for improving the mathematical, statistical or
clinical concepts in the model?
|
|
2
|
- 2. How does the committee envision such a model can be best
utilized to improve drug development?
|
|
3
|
- 3. Does the committee have any general recommendations for further
exploratory research into drug disease models?
|
Notes
